Vx-950



Indications and Reactions:

Role Indications Reactions
Primary
Hepatitis C 87.3%
Hypertension 2.3%
Product Used For Unknown Indication 1.3%
Hiv Infection 1.3%
Depression 1.0%
Anaemia 0.8%
Diabetes Mellitus 0.8%
Rash 0.7%
Chronic Hepatitis C 0.6%
Anxiety 0.5%
Type 2 Diabetes Mellitus 0.5%
Hypothyroidism 0.4%
Insomnia 0.4%
Pruritus 0.3%
Gastrooesophageal Reflux Disease 0.3%
Headache 0.3%
Insulin Resistance 0.3%
Nutritional Support 0.3%
Prophylaxis 0.2%
Pain 0.2%
Rash 18.3%
White Blood Cell Count Decreased 10.6%
Fatigue 8.2%
Vomiting 7.5%
Anaemia 7.1%
Nausea 6.6%
Pruritus 6.3%
Weight Decreased 4.9%
Influenza Like Illness 3.9%
Drug Ineffective 3.6%
Pyrexia 3.2%
Rash Generalised 2.6%
Rash Pruritic 2.5%
Neutropenia 2.4%
Malaise 2.3%
Drug Intolerance 2.2%
Neutrophil Count Decreased 2.1%
Renal Impairment 2.0%
Drug Rash With Eosinophilia And Systemic Symptoms 1.9%
Thrombocytopenia 1.8%
Secondary
Hepatitis C 68.8%
Product Used For Unknown Indication 6.5%
Hypertension 3.2%
Rash 2.7%
Depression 2.3%
Nausea 1.8%
Hiv Infection 1.7%
Chronic Hepatitis C 1.6%
Diabetes Mellitus 1.6%
Headache 1.6%
Back Pain 1.5%
Insomnia 1.0%
Asthma 0.9%
Anxiety 0.9%
Vitamin Supplementation 0.9%
Prophylaxis 0.7%
Cardiac Failure 0.6%
Pain In Extremity 0.6%
Hypothyroidism 0.5%
Pruritus 0.5%
White Blood Cell Count Decreased 17.2%
Rash 10.3%
Renal Impairment 8.4%
Renal Failure Acute 7.4%
Renal Disorder 6.4%
Anaemia 5.4%
Neutrophil Count Decreased 5.4%
Nausea 4.4%
Subcutaneous Abscess 4.4%
Syncope 4.4%
Haemoglobin Decreased 3.9%
Blood Creatinine Increased 3.4%
Renal Failure 3.0%
Demyelinating Polyneuropathy 2.5%
Pulmonary Embolism 2.5%
Pyrexia 2.5%
Vomiting 2.5%
Decreased Appetite 2.0%
Drug Eruption 2.0%
Malaise 2.0%
Concomitant
Hepatitis C 39.6%
Product Used For Unknown Indication 20.8%
Back Pain 8.3%
Constipation 4.2%
Diabetes Mellitus 4.2%
Headache 4.2%
Abdominal Pain Upper 2.1%
Appetite Disorder 2.1%
Depression 2.1%
Hypertension 2.1%
Hypothyroidism 2.1%
Myalgia 2.1%
Nausea 2.1%
Pain 2.1%
Rash 2.1%
Mallory-weiss Syndrome 57.1%
Malaise 14.3%
Renal Failure 14.3%
Renal Failure Acute 14.3%